The goal
To create an engaging infographic to summarise the mechanism of action, clinical trial design and initial findings for Debiopharm’s theranostic pair, Debio 0328/0228, for use on social media.
To create an engaging infographic to summarise the mechanism of action, clinical trial design and initial findings for Debiopharm’s theranostic pair, Debio 0328/0228, for use on social media.
To ensure accuracy, we began by conducting research into clear cell renal cell carcinoma and the mechanism of action of Debio 0328/0228. This included a thorough review of the clinical trial publication.
We condensed the publication’s key information into content for four separate tiles, each focused on one area: background, methods, findings, and conclusions.
Using the curated content, we designed four visually consistent and engaging infographic tiles. These tiles effectively illustrated the theranostic pair’s mechanism and the trial outcomes in a simplified and appealing format.
The completed infographic was shared on the client’s social media. It provided a clear and concise summary of the clinical trial findings, encouraging the audience to read the full publication.
It appealed to the scientists in us. It was incredibly rewarding to transform complex clinical data into a simplified format, making critical research more accessible for a broader audience. Projects like these play an important role in promoting engagement with key scientific findings.